share_log

Phibro Animal Health Analyst Ratings

Phibro Animal Health Analyst Ratings

Phibro 动物健康分析师评级
Benzinga ·  2023/09/01 11:49
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
09/01/2023 47.16% Roth MKM → $21 Reiterates Buy → Buy
08/31/2023 19.13% Morgan Stanley $18 → $17 Maintains Equal-Weight
08/29/2023 47.16% Roth MKM → $21 Reiterates Buy → Buy
07/27/2023 26.14% Morgan Stanley $18 → $18 Reiterates Equal-Weight → Equal-Weight
05/04/2023 26.14% Morgan Stanley $19 → $18 Maintains Equal-Weight
02/09/2023 33.15% Morgan Stanley $20 → $19 Maintains Equal-Weight
12/21/2022 26.14% Roth Capital → $18 Initiates Coverage On → Buy
11/10/2022 40.15% Morgan Stanley $21 → $20 Maintains Equal-Weight
09/16/2022 19.13% Barclays $22 → $17 Maintains Underweight
08/26/2022 47.16% Morgan Stanley $23 → $21 Maintains Equal-Weight
07/25/2022 54.17% Barclays → $22 Downgrades Equal-Weight → Underweight
01/10/2022 61.18% Barclays → $23 Upgrades Underweight → Equal-Weight
11/18/2021 61.18% Morgan Stanley → $23 Initiates Coverage On → Equal-Weight
07/07/2021 61.18% Barclays → $23 Downgrades Equal-Weight → Underweight
05/13/2021 54.17% Morgan Stanley $19 → $22 Maintains Underweight
05/08/2020 61.18% Credit Suisse $25 → $23 Maintains Neutral
02/06/2020 Gabelli & Co. Downgrades Buy → Hold
01/28/2020 61.18% Barclays → $23 Upgrades Underweight → Equal-Weight
09/05/2019 47.16% Morgan Stanley $30 → $21 Upgrades Underweight → Equal-Weight
08/29/2019 26.14% B of A Securities $29 → $18 Reiterates → Underperform
08/29/2019 26.14% Barclays $25 → $18 Maintains Underweight
08/28/2019 75.19% Credit Suisse $31 → $25 Reiterates → Neutral
06/11/2019 75.19% Barclays → $25 Initiates Coverage On → Underweight
05/09/2019 Gabelli & Co. Upgrades Hold → Buy
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
09/01/2023 47.16% 罗斯MKM →$21 重申 购买→购买
2023年08月31日 19.13% 摩根士丹利 $18→$17 维护 等重
2023年08月29日 47.16% 罗斯MKM →$21 重申 购买→购买
07/27/2023 26.14% 摩根士丹利 $18→$18 重申 等重→等重
05/04/2023 26.14% 摩根士丹利 $19→$18 维护 等重
02/09/2023 33.15% 摩根士丹利 $20→$19 维护 等重
2022年12月21日 26.14% 罗斯资本 →$18 开始承保 →购买
2022年11月10日 40.15% 摩根士丹利 $21→$20 维护 等重
09/16/2022 19.13% 巴克莱 $22→$17 维护 体重不足
2022年08月26日 47.16% 摩根士丹利 $23→$21 维护 等重
07/25/2022 54.17% 巴克莱 →$22 评级下调 等重→减码
2022年1月10日 61.18% 巴克莱 →$23 升级 重量不足的→等重
2021年11月18日 61.18% 摩根士丹利 →$23 开始承保 →等重
07/07/2021 61.18% 巴克莱 →$23 评级下调 等重→减码
2021/05/13 54.17% 摩根士丹利 $19→$22 维护 体重不足
05/08/2020 61.18% 瑞士信贷 $25→$23 维护 中性
02/06/2020 - 加贝利公司 评级下调 购买→Hold
1/28/2020 61.18% 巴克莱 →$23 升级 重量不足的→等重
2019年05月09日 47.16% 摩根士丹利 $30→$21 升级 重量不足的→等重
2019年08月29日 26.14% B of A证券 $29→$18 重申 →表现不佳
2019年08月29日 26.14% 巴克莱 $25→$18 维护 体重不足
2019年08月28日 75.19% 瑞士信贷 $31→$25 重申 →中性
2019年6月11日 75.19% 巴克莱 →$25 开始承保 →减持
2019年05月09日 - 加贝利公司 升级 持有→购买

What is the target price for Phibro Animal Health (PAHC)?

Phibro Animal Health(PAHC)的目标价格是多少?

The latest price target for Phibro Animal Health (NASDAQ: PAHC) was reported by Roth MKM on September 1, 2023. The analyst firm set a price target for $21.00 expecting PAHC to rise to within 12 months (a possible 47.16% upside). 9 analyst firms have reported ratings in the last year.

罗斯MKM于2023年9月1日报道了菲布罗动物健康公司(纳斯达克:PAHC)的最新目标价。这家分析公司将目标价定为21.00美元,预计PAHC将在12个月内上涨至47.16%(可能上涨47.16%)。去年有9家分析公司公布了评级。

What is the most recent analyst rating for Phibro Animal Health (PAHC)?

菲布罗动物健康(PAHC)的最新分析师评级是多少?

The latest analyst rating for Phibro Animal Health (NASDAQ: PAHC) was provided by Roth MKM, and Phibro Animal Health reiterated their buy rating.

菲布罗动物健康公司(纳斯达克代码:PAHC)的最新分析师评级由Roth MKM提供,菲布罗动物健康公司重申了他们的买入评级。

When is the next analyst rating going to be posted or updated for Phibro Animal Health (PAHC)?

菲布罗动物健康(PAHC)的下一次分析师评级将于何时发布或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Phibro Animal Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Phibro Animal Health was filed on September 1, 2023 so you should expect the next rating to be made available sometime around September 1, 2024.

分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与菲布罗动物健康公司的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。菲布罗动物健康的上一次评级是在2023年9月1日提交的,所以你应该预计下一次评级将在2024年9月1日左右的某个时候公布。

Is the Analyst Rating Phibro Animal Health (PAHC) correct?

分析师对Phibro Animal Health(PAHC)的评级正确吗?

While ratings are subjective and will change, the latest Phibro Animal Health (PAHC) rating was a reiterated with a price target of $0.00 to $21.00. The current price Phibro Animal Health (PAHC) is trading at is $14.27, which is within the analyst's predicted range.

虽然评级是主观的,并将发生变化,但菲布罗动物健康(PAHC)的最新评级被重申,目标价在0.00美元至21.00美元之间。Phibro Animal Health(PAHC)目前的交易价格为14.27美元,在分析师的预测范围内。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发